Myoforte Therapeutics, Inc.
PrivateLast Round
Corporate Funding
Dec 1, 2024
Total Funding Raised
$85M
Company Overview
Myoforte Therapeutics, Inc. is a biopharmaceutical company that develops small molecule drugs designed to enhance muscle regeneration and strength by targeting muscle stem cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myoforte Therapeutics, Inc. Comparables
Compare Myoforte Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epirium Bio | 90% | |
| Sarcomatrix Therapeutics Corp. | 85% | |
| Rejuvenate Biomed | 81% |
Myoforte Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 1, 2024 | ||||
| Series A | Dec 18, 2019 |
Myoforte Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series A, Corporate Funding |
| Vertex Ventures HC | Series A, Corporate Funding |
| ARCH Venture Partners | Series A, Corporate Funding |
| Bluebird Ventures | Series A, Corporate Funding |
| The Longevity Fund | Series A, Corporate Funding |
| Adams Street Partners | Series A, Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2024
Raised corporate funding from ARCH Venture Partners and others.
- Dec 18, 2019
$85M round with ARCH Venture Partners and Bluebird Ventures.
Myoforte Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Myoforte Therapeutics, Inc.'s valuation, stock price, and market status.
Is Myoforte Therapeutics, Inc. a public or private company?
Myoforte Therapeutics, Inc. is a private company.
What is the current stock price of Myoforte Therapeutics, Inc.?
Myoforte Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Myoforte Therapeutics, Inc. worth (valuation)?
Valuation information for Myoforte Therapeutics, Inc. is not publicly available.
Can I buy Myoforte Therapeutics, Inc. stock?
Myoforte Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Myoforte Therapeutics, Inc.'s last funding round?
Myoforte Therapeutics, Inc.'s most recent funding round was Series A on December 18, 2019.
Who are the main investors in Myoforte Therapeutics, Inc.?
Key investors in Myoforte Therapeutics, Inc. include Longitude Capital, Vertex Ventures HC, ARCH Venture Partners, Bluebird Ventures, The Longevity Fund.
Will Myoforte Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Myoforte Therapeutics, Inc..
How can I track Myoforte Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Myoforte Therapeutics, Inc.'s secondary market activity and sign up for updates.